61 related articles for article (PubMed ID: 2599004)
21. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.
Ladhani S; Joannou CL; Lochrie DP; Evans RW; Poston SM
Clin Microbiol Rev; 1999 Apr; 12(2):224-42. PubMed ID: 10194458
[TBL] [Abstract][Full Text] [Related]
22. Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.
Cole BC; Sawitzke AD; Ahmed EA; Atkin CL; David CS
Infect Immun; 1997 Oct; 65(10):4190-8. PubMed ID: 9317026
[TBL] [Abstract][Full Text] [Related]
23. An insulin peptide that binds an alternative site in class II major histocompatibility complex.
Tompkins SM; Moore JC; Jensen PE
J Exp Med; 1996 Mar; 183(3):857-66. PubMed ID: 8642290
[TBL] [Abstract][Full Text] [Related]
24. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells.
Wen R; Cole GA; Surman S; Blackman MA; Woodland DL
J Exp Med; 1996 Mar; 183(3):1083-92. PubMed ID: 8642250
[TBL] [Abstract][Full Text] [Related]
25. Superantigens and pseudosuperantigens of gram-positive cocci.
Fleischer B; Gerlach D; Fuhrmann A; Schmidt KH
Med Microbiol Immunol; 1995 May; 184(1):1-8. PubMed ID: 8538573
[TBL] [Abstract][Full Text] [Related]
26. Bacterial and viral superantigens: roles in autoimmunity?
Acha-Orbea H
Ann Rheum Dis; 1993 Mar; 52 Suppl 1(Suppl 1):S6-16. PubMed ID: 8481060
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.
Stiles BG; Bavari S; Krakauer T; Ulrich RG
Infect Immun; 1993 Dec; 61(12):5333-8. PubMed ID: 8225606
[TBL] [Abstract][Full Text] [Related]
28. Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins.
Beharka AA; Armstrong JW; Iandolo JJ; Chapes SK
Infect Immun; 1994 Sep; 62(9):3907-15. PubMed ID: 8063407
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.
Hudson KR; Tiedemann RE; Urban RG; Lowe SC; Strominger JL; Fraser JD
J Exp Med; 1995 Sep; 182(3):711-20. PubMed ID: 7650479
[TBL] [Abstract][Full Text] [Related]
30. Staphylococcal enterotoxins bind H-2Db molecules on macrophages.
Beharka AA; Iandolo JJ; Chapes SK
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6294-8. PubMed ID: 7603985
[TBL] [Abstract][Full Text] [Related]
31. Microbial "superantigens".
Misfeldt ML
Infect Immun; 1990 Aug; 58(8):2409-13. PubMed ID: 2196226
[No Abstract] [Full Text] [Related]
32. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.
Herman A; Croteau G; Sekaly RP; Kappler J; Marrack P
J Exp Med; 1990 Sep; 172(3):709-17. PubMed ID: 2117633
[TBL] [Abstract][Full Text] [Related]
34. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.
Herman A; Labrecque N; Thibodeau J; Marrack P; Kappler JW; Sekaly RP
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9954-8. PubMed ID: 1946464
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
36. Staphylococcal exotoxins stimulate nitric oxide-dependent murine macrophage tumoricidal activity.
Fast DJ; Shannon BJ; Herriott MJ; Kennedy MJ; Rummage JA; Leu RW
Infect Immun; 1991 Sep; 59(9):2987-93. PubMed ID: 1908828
[TBL] [Abstract][Full Text] [Related]
37. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor.
Newell KA; Ellenhorn JD; Bruce DS; Bluestone JA
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):1074-8. PubMed ID: 1899481
[TBL] [Abstract][Full Text] [Related]
38. T lymphocyte-stimulating microbial toxins as "superantigens".
Fleischer B
Med Microbiol Immunol; 1991; 180(2):53-8. PubMed ID: 1881366
[TBL] [Abstract][Full Text] [Related]
39. Involvement of HLA class II molecules in acquisition of staphylococcal enterotoxin A-binding activity and accessory cell activity in activation of human T cells by related toxins in vascular endothelial cells.
Uchiyama T; Araake M; Yan XJ; Miyanaga Y; Igarashi H
Clin Exp Immunol; 1992 Feb; 87(2):322-8. PubMed ID: 1735196
[TBL] [Abstract][Full Text] [Related]
40. Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen.
Fleischer B; Bailey CJ
Med Microbiol Immunol; 1992; 180(6):273-8. PubMed ID: 1549069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
